Evidence map›Paper›PMID 26345627›Full record

ArticleInternational journal of nanomedicine2015

Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties.

Didier Betbeder, Emmanuelle Lipka, Mike Howsam, Rodolphe Carpentier

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Curcumin Inhibits Oxidative Stress and Apoptosis Induced by HAnimals : an open access journal from MDPI · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Reactive Oxygen Species-Regulating Strategies Based on Nanomaterials for Disease Treatment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  9. HSA-curcumin nanoparticles: a promising substitution for Curcumin as a Cancer chemoprevention and therapy.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Didier BetbederU995-LIRIC, Inserm (Institut National de la Recherche Médicale), Lille, France ; U995-LIRIC, CHRU de Lille, Lille, France ; U995-LIRIC, Faculté de Médecine, Université de Lille, Lille, France ; Faculté des Sciences du Sport, Université d'Artois, Arras, France.
Emmanuelle LipkaU995-LIRIC, Inserm (Institut National de la Recherche Médicale), Lille, France ; U995-LIRIC, CHRU de Lille, Lille, France ; Faculté de Pharmacie, Université de Lille, Lille, France.
Mike HowsamFaculté de Pharmacie, Université de Lille, Centre Universitaire de Mesures et d'Analyses, Lille, France.
Rodolphe CarpentierU995-LIRIC, Inserm (Institut National de la Recherche Médicale), Lille, France ; U995-LIRIC, CHRU de Lille, Lille, France ; U995-LIRIC, Faculté de Médecine, Université de Lille, Lille, France.
Université de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCurcumin exhibits antioxidant properties potentially beneficial for human health; however, its use in clinical applications is limited by its poor solubility and relative instability. Nanoparticles exhibit interesting features for the efficient distribution and delivery of curcumin into cells, and could also increase curcumin stability in biological systems. There is a paucity of information regarding the evolution of the antioxidant properties of nanoparticle-encapsulated curcumin.

methodWe described a simple method of curcumin encapsulation in poly-lactic-co-glycolic acid (PLGA) nanoparticles without the use of detergent. We assessed, in epithelial cells and in an acellular model, the evolution of direct antioxidant and antinitrosant properties of free versus PLGA-encapsulated curcumin after storage under different conditions (light vs darkness, 4°C vs 25°C vs 37°C).

resultsIn epithelial cells, endocytosis and efflux pump inhibitors showed that the increased antioxidant activity of PLGA-encapsulated curcumin relied on bypassing the efflux pump system. Acellular assays showed that the antioxidant effect of curcumin was greater when loaded in PLGA nanoparticles. Furthermore, we observed that light decreased, though heat restored, antioxidant activity of PLGA-encapsulated curcumin, probably by modulating the accessibility of curcumin to reactive oxygen species, an observation supported by results from quenching experiments. Moreover, we demonstrated a direct antinitrosant activity of curcumin, enhanced by PLGA encapsulation, which was increased by light exposure.

conclusionThese results suggest that the antioxidant and antinitrosant activities of encapsulated curcumin are light sensitive and that nanoparticle modifications over time and with temperature may facilitate curcumin contact with reactive oxygen species. These results highlight the importance of understanding effects of nanoparticle maturation on an encapsulated drug's activity.

Indexed as

AntioxidantsCell Line, TumorCurcuminDetergentsDrug Delivery SystemsEndocytosisGlycolatesHumansLactic AcidNanoparticlesNitrogenPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerReactive Oxygen SpeciesSolubilityTemperatureAntioxidantsCurcuminDetergentsGlycolatesglycolic acidLactic AcidNitrogenPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerReactive Oxygen SpeciesantioxidantcurcuminevolutionmaturationPLGA nanoparticles

Identifiers

PMID26345627
PMCPMC4554401
OpenAlexW1706201800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.